Checking biomarkers after a liver transplant
Part of Digestive system, Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are receiving a liver transplant (first or repeat; from living or deceased donors)
- You (or your legal guardian) can give informed consent
- You (or your caregiver/guardian) can follow the study plan and visits
- You are willing and able to participate—no refusal or inability to consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study tracks early signs of immune system changes in children who received a liver transplant 3–7 years ago and are doing well. By studying blood and liver samples, researchers hope to better understand how to prevent rejection and improve long-term transplant survival.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
This study is following people who have had a liver, kidney, heart, or lung transplant. It will look for markers in your blood that might help predict how you do in the short and long term after transplant.
This study looks at how well noninvasive tests (tests that don’t require surgery or taking tissue) can detect complications after a liver transplant. It may help patients and teams find problems earlier using safer, easier monitoring.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
Hear when a new Liver Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.